The metabolic transition of liver cancer: a 34-year analysis of global burden across the 10 most populous countries, 1990–2023
- 1Department of Anesthesiology, The First People's Hospital of Zhaoqing , , ,
- 2Department of Oncology, The First Affiliated Hospital of Jinan University , , ,
- 3Department of Anesthesiology, The First Affiliated Hospital of Jinan University , , ,
Abstract
Background:: The global burden of liver cancer continues to rise, yet comprehensive assessments of trends in behavioral and metabolic risk factor-attributable mortality and disability-adjusted life years (DALYs) remain limited. We aimed to quantify these trends across the world's 10 most populous countries from 1990 to 2023.
Methods: Using data from the Global Burden of Disease Study 2023, we extracted age-standardized mortality rates (ASMRs) and disability-adjusted life years (DALYs) for primary liver cancer attributable to seven risk factors—two composite exposures (behavioral risks and metabolic risks) and five component exposures (alcohol use, tobacco, drug use, high body mass index, and high fasting plasma glucose)—globally and across the 10 most populous nations. All burden estimates are reported with 95% uncertainty intervals (UIs). Joinpoint regression analysis identified temporal trend changes by sex and country, with annual percentage changes (APCs) and average annual percentage changes (AAPCs) reported with 95% confidence intervals (CIs).
Findings: Globally, alcohol remained the predominant behavioral risk, although alcohol use-attributable ASMRs changed little across the study period [1.08 [95% UI 0.83–1.46] to 1.13 [0.87–1.46] per 100,000; AAPC 0.06% [95% CI −0.01 to 0.14], p = 0.07]. Concerningly, drug use-related ASMRs rose by 79% [0.40 [0.28–0.59] to 0.73 [0.56–0.92] per 100,000; AAPC 1.78% [1.68–1.87]], while metabolic risk-attributable mortality increased 71% [0.42 [0.24–0.64] to 0.73 [0.40–1.05] per 100,000; AAPC 1.67% [1.60–1.73]] and high body mass index-related DALYs nearly doubled [8.96 [3.90–14.82] to 16.26 [7.50–25.62] per 100,000]. Marked heterogeneity existed across countries: by 2023 Nigeria exhibited male metabolic risk-related DALYs nearly four times the global average [95.17 [34.23–204.38] vs. 25.13 [13.61–38.01] per 100,000]. Among women, behavioral and metabolic risk burdens increased in most countries, with the United States showing 2–3-fold higher rates than global averages.
Interpretation: While traditional behavioral risk factors stabilized, metabolic risks and drug use now account for a growing share of liver cancer burden globally, with an apparent acceleration after 2020. These findings are restricted to the 10 most populous countries and therefore do not represent Europe, the Middle East, or most of Africa, and the ecological design precludes individual-level causal inference. Integrated prevention strategies targeting obesity, diabetes, and substance use disorders are nonetheless likely to be important, particularly in rapidly developing nations and among women.
Related
- Global burden, geographic and sex disparities, and projections to 2050 for salivary gland cancer across G20 countries: a GLOBOCAN 2024 analysis
- Trends, Risk Factors, and Future Burden of Female Breast Cancer in China and Other G20 Countries, 1990-2050: A Comparative Global Burden of Disease 2023 Analysis.
- Trends in the Asthma Burden Attributable to High Body Mass Index in Children Across 204 Countries and Territories, 1990–2021: An Analysis of the 2021 Global Burden of Disease Study
- Burden of Five Musculoskeletal Disorders in ASEAN Countries, 1990–2023: A Global Burden of Disease Study 2023 Analysis
- Strengthening public universities in low- and middle-income countries to improve global health equity.
BibTeX
@article{luo2026metabolic,
title = {{The metabolic transition of liver cancer: a 34-year analysis of global burden across the 10 most populous countries, 1990–2023}},
author = {Qichen Luo and Sisi Lan and Jinfeng Chen and Jingru Han and Simeng Gao and Yalan Li and Haihong Deng and Yang Zhao},
journal = {Frontiers in public health},
year = {2026},
month = oct,
doi = {10.3389/fpubh.2026.1945748},
url = {https://europepmc.org/article/PMC/PMC13690718},
note = {CC BY},
}
RIS
TY - JOUR
TI - The metabolic transition of liver cancer: a 34-year analysis of global burden across the 10 most populous countries, 1990–2023
AU - Qichen Luo
AU - Sisi Lan
AU - Jinfeng Chen
AU - Jingru Han
AU - Simeng Gao
AU - Yalan Li
AU - Haihong Deng
AU - Yang Zhao
PY - 2026
DA - 2026/10/09
JO - Frontiers in public health
DO - 10.3389/fpubh.2026.1945748
UR - https://europepmc.org/article/PMC/PMC13690718
AB - Background:: The global burden of liver cancer continues to rise, yet comprehensive assessments of trends in behavioral and metabolic risk factor-attributable mortality and disability-adjusted life years (DALYs) remain limited. We aimed to quantify these trends across the world's 10 most populous countries from 1990 to 2023. Methods: Using data from the Global Burden of Disease Study 2023, we extracted age-standardized mortality rates (ASMRs) and disability-adjusted life years (DALYs) for primary liver cancer attributable to seven risk factors—two composite exposures (behavioral risks and metabolic risks) and five component exposures (alcohol use, tobacco, drug use, high body mass index, and high fasting plasma glucose)—globally and across the 10 most populous nations. All burden estimates are reported with 95% uncertainty intervals (UIs). Joinpoint regression analysis identified temporal trend changes by sex and country, with annual percentage changes (APCs) and average annual percentage changes (AAPCs) reported with 95% confidence intervals (CIs). Findings: Globally, alcohol remained the predominant behavioral risk, although alcohol use-attributable ASMRs changed little across the study period [1.08 [95% UI 0.83–1.46] to 1.13 [0.87–1.46] per 100,000; AAPC 0.06% [95% CI −0.01 to 0.14], p = 0.07]. Concerningly, drug use-related ASMRs rose by 79% [0.40 [0.28–0.59] to 0.73 [0.56–0.92] per 100,000; AAPC 1.78% [1.68–1.87]], while metabolic risk-attributable mortality increased 71% [0.42 [0.24–0.64] to 0.73 [0.40–1.05] per 100,000; AAPC 1.67% [1.60–1.73]] and high body mass index-related DALYs nearly doubled [8.96 [3.90–14.82] to 16.26 [7.50–25.62] per 100,000]. Marked heterogeneity existed across countries: by 2023 Nigeria exhibited male metabolic risk-related DALYs nearly four times the global average [95.17 [34.23–204.38] vs. 25.13 [13.61–38.01] per 100,000]. Among women, behavioral and metabolic risk burdens increased in most countries, with the United States showing 2–3-fold higher rates than global averages. Interpretation: While traditional behavioral risk factors stabilized, metabolic risks and drug use now account for a growing share of liver cancer burden globally, with an apparent acceleration after 2020. These findings are restricted to the 10 most populous countries and therefore do not represent Europe, the Middle East, or most of Africa, and the ecological design precludes individual-level causal inference. Integrated prevention strategies targeting obesity, diabetes, and substance use disorders are nonetheless likely to be important, particularly in rapidly developing nations and among women.
SN - 2296-2565
ER -